✨ 53 results found - Searched 22785 records in 4ms.
Disertasi
Peran Kadar Plasma, Rasio Cmax/MIC Bedaquilin dan Lecofloksasin terhadap Luaran Terapi TB Multidrug Resistant
2025 | BY Nina Mariana - Purwantyastuti Ascobat - Anggi Gayatri - Indah Suci Widyahening- Role ofPlasma Concentrations, Cmax/MIC Ratio of Bedaquiline and Levofloxacin on The Outcome of MDR-TB Treatment.
- Nomor Panggil D25041fk
Skripsi
Hubungan Efek Samping Obat Anti Tuberkulosis (OAT) Lini Pertama dengan Keberlanjutan Pengobatan Pasien Tuberkulosis (TB) Paru di RSCM Tahun 2014
2016 | BY Stefanus Imanuel Setiawan - PURWANTYASTUTI- First Line Anti-tuberculosis Drugs Adverse Reactions as a Risk to Pulmonary Tuberculosis Treatment Default in Dr. Cipto Mangunkusumo National General Hospital.
- Nomor Panggil S16035FK
Skripsi
Pola Penggunaan Antibiotik Fluoroquinolones di Puskesmas Depok pada Infeksi NON-TB
2024 | BY Muhammad Hatta Hakim - Purwantyastuti Ascobat- Pattern of Fluoroquinolones Antibiotic Use in Depok Community Health Center for NON-TB Infections.
- Nomor Panggil S24071fk
Skripsi
POLA PENGGUNAAN ANTIBIOTIK GOLONGAN FLUOROKUINOLON PADA PASIEN NON-TB DI INSTALASI RAWAT JALAN RSUI DEPOK TAHUN 2023
2024 | BY Rizqi Indirsyah Faiq - Purwantyastuti Ascobat- PATTERNS OF USE OF FLUOROQUINOLONE ANTIBIOTICS IN NON-TB PATIENTS IN THE OUTPATIENT INSTALLATION OF RSUI DEPOK IN 2023.
- Nomor Panggil S24062fk
Skripsi
Pola Penggunaan Antibiotik Golongan Fluorokuinolon pada Pasien Rawat Jalan non-TB di RSUD Khidmat Sehat Afiat Kota Depok tahun 2023.
2024 | BY Ilham Fauzan Rahman - Purwantyastuti Ascobat- Nomor Panggil S24024fk
Skripsi
Compliance in MDR-TB patients during primary TB treatment : its association with the accessibility of free drugs.
2010 | BY Nicolaus Novian Wahjoepramono - PURWANTYASTUTI- Kepatuhan Pasien MDR-TB Terhadap Pengobatan TB Pertama: Peran Pemberian Obat Gratis Terhadap Kepatuhan Pasien MDR-TB selama pengobatan TB pertama.
- Nomor Panggil S10285fk
Tesis
Analisis Potensi Interaksi Obat Pada Tatalaksana Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut di RS Kanker Dharmais Tahun 2023
2024 | BY Anggi Gayatri - Purwantyastuti Ascobat - Noorwati Soetandyo - Yolanda Safitri- Analysis of Potential Drug Interactions in the Management of Non-Small Cell Carcinoma Lung Cancer (NSCLC) Advanced Stage at Dharmais Cancer Hospital in 2023.
- Nomor Panggil T24404fk
Disertasi
Pengaruh deksametason terhadap proliferasi sel, kadar interleukin-1α, dan tumor necrosis faktor-α pada biakan kolesteatoma pasien otitis media supuratif kronik.
2005 | BY Ratna Dwi Restuti - Hendarto Hendarmin - Alida R. Harahap - PURWANTYASTUTI- Nomor Panggil D05010fk
Disertasi
Hubungan konsentrasi rifampisin darah dengan respons pengobatan berdasarkan hasil biakan kuman mycobacterium tuberculosis pada pasien TB paru yang diobati dengan kombinasi dosis tetap (KDT).
2012 | BY Erlina Burhan - Hadiarto Mangunnegoro - Purwantyastuti Ascobat - Reinout Van Crevel- Association between plasma rifampisin concentration and treatment response in pulmonary TB patients treated with fixed-dosed combination regimen (FDC) based on culture of myobacterium tuberculosis.
- Nomor Panggil D12013fk
Disertasi
Invitro, Exvivo and Clinical Studies onAnnona muricata Leaves for Colorectal Cancer.
2015 | BY PURWANTYASTUTI - LILI INDRAWATI - Murdani Abdullah- Nomor Panggil D15009fk